Alzheimer's disease biomarkers in different deffinitons ofsubjective cognitive decline
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
the emergence of the clinical symptoms in Alzheimer's Disease (AD) patients. For early diagnosis, pre-dementia clinical stages were identified. Subjective Cognitive Impairment refers to a clinical state of which no objective neuropsychological impairment is observed in individuals with cognitive complaints. Currently there is no consensus on the operationalization of SCD criteria. The aim of this study is to assess structural neuroimaging biomarkers of AD in different definitions of SCD. The study included 101 participants over 55 years of age, with memory complaints and no identifiable impairment in the Modified Mini Mental Test. We evaluated whether (i) using a valid scale (Subjective Memory Complaints Questionnaire-SMCQ) rather than a single question; (ii) utilizing neuropsychological test data in addition to a screening test; (iii) evaluating SCD + criteria –additional qualitative features of the complaintand (iv) the exclusion of comorbidities that may be associated with memory complaints; would be associated with increased atrophy in AD-related areas. Three different cortical thickness and two cortical volume patterns were determined as the dependent variables. Results suggested that age, sex, age of onset of memory complaints, depression or anxiety symptoms and vitamin B12 and vitamin D levels were associated with alterations in the structural markers of AD. Regarding different definitions of SCD; assessment of SCD + criteria, utilizing SMCQ, addition of neuropsychological test data and excluding individuals with comorbidities did not contribute to the validity of SCD in terms of the AD morphology. Our findings indicate the importance of psychiatric evaluation in individuals with subjective memory complaints. The presence of depression and anxiety symptoms in a person with SCD may increase the likelihood of AD-related brain morphological changes. Longitudinal studies, better assessment of the phenotype, inclusion of different diagnostic groups may help to refine the definition of SCD and the addition of criterion which may point to early morphological changes.
Author
Ahmet Alp Karakaşlı
How to Cite
Ahmet Alp Karakaşlı (Medical Specialty Thesis). Alzheimer's disease biomarkers in different deffinitons ofsubjective cognitive decline, 2019, Hacettepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Hacettepe University
- Elementler ve insan doğası arasındaki uyuşmazlık: Ekofobi ve Rönesans İngiliz tiyatrosu(2018)
- Gençlerin ve Gençlik Çalışanlarının Gözünden Gençlik Politikaları ve Hizmetlerinin Değerlendirilmesi(2022)
- An analysis of the intonation patterns of if-clauses in Turkish English majors(2017)
- Characterization of Ayvalik (Edremit yaglik) extra virgin olive oils volatile compounds with SPME-GC/MS and Raman spectroscopy(2018)
- A critical evaluation of pronunciation teaching in an ELT department in Turkey(2023)
- The effect of child labor related boycott threat on Ivory Coast cocoa production(2018)
